doi: 10.25005/2074-0581-2020-22-2-237-240

M.A. Medvedev1, B.Kh. Bebezov2, N.A. Turgunbaev1, A.I. Ostroverkhov1

1Department of Ophthalmology, Medical Faculty, Kyrgyz-Russian Slavic University, Bishkek, Kyrgyz Republic
2Department of Hospital Surgery, Medical Faculty, Kyrgyz-Russian Slavic University, Bishkek, Kyrgyz Republic

Objective: To study the effectiveness and safety of using a combination of lamellar keratoplasty and cross-linking in the treatment of keratoconus.

Methods: There nine patients (9 eyes) with keratoconus of stage III (Amsler) on the worst eye were under surveillance. The patients before and afterward the surgery were performed visometry, biomicroscopy, and ophthalmometry. In all cases, the operation was performed on the eye with lower visual acuity. The excision of corneal tissue up to the Descemet’s membrane was carried out using a zirconium (fianite) exfoliator. The diameter of the graft corresponded to the diameter of the tissue bed. After applying four fixing silk sutures (silk 8.0) have put in the continuous stitches of 10.0 size (nylon, supramide). Before starting the cross-linking procedure, an intrastromal donor transplanted cornea was saturated with an insulin syringe with a 0.1% riboflavin solution. The surgical field was subsequently exposed to UVA irradiation with a wavelength of 370 nm according to the express method. All patients were followed up for a period of 6 months up to 5 years.

Results: Total epithelization in all cases is noted for the first 24 hours. Early medicinal therapy in the postoperative period included the appointment of antibiotics and corticosteroids in instillations. A continuous suture in all cases was removed between the 3rd and 4th month after surgery. By the 6th month after the operation, uncorrected visual acuity was 0.39±0.12. The maximum corrected visual acuity was 0.47±0.11. The average level of postkeratoplastic astigmatism was 2.66±0.97D.

Conclusion: It can be considered, that the biological results of lamellar keratoplasty exceed those of the through corneal transplant. While the functional results of lamellar keratoplasty with the cross-linking application are slightly lower than those of the through keratoplasty; which explained to the availability of the additional refraction plane (interface).

Keywords: Keratoconus, keratoplasty, cross-linking, visual acuity, transplant..

Download file:

  1. Kankariya VP, Kymionis GD, Diakonis VF, Yoo SH. Management of pediatric keratoconus – Evolving role of corneal collagen cross-linking: An update. Indian J Ophthalmol. 2013;61(8):435-40.
  2. Kurna SA, Altun A, Gencaga T, Akkaya S, Sengor T. Vision related quality of life in patients with keratoconus. J Ophthalmol. 2014;2014:694542.
  3. Bao FJ, Geraghty B, Wang QM, Elsheikh A. Consideration of corneal biomechanics in the diagnosis and management of keratoconus: is it important? Eye Vis. 2016;3:18.
  4. Rao SK. Collagen cross-linking: Current perspectives. Indian J Ophthalmol. 2013;61(8):420-1.
  5. Sachdev GS, Sachdev M. Recent advances in corneal collagen cross-linking. Indian J Ophthalmol. 2017;65(9):787-96.
  6. Strmeňová E, Vlková E, Michalcová L, Trnková V, Dvořáková D, Goutaib M, et al. The effectiveness of corneal cross-linking in stopping the progression of keratoconus. Cesk Slov Oftalmol. 2014;70(6):218-22.
  7. Wan Q, Wang D, Ye HQ, Tang J, Han Y. A review and meta-analysis of corneal cross-linking for post-laser vision correction ectasia. J Curr Ophthalmol. 2017;29(3):145-53.
  8. Song W, Tang Y, Qiao J, Li H, Rong B, Yang S, et al. The comparative safety of genipin versus UVA-riboflavin crosslinking of rabbit corneas. Mol Vis. 2017;23:504-13.
  9. Alhayek A, Lu P-R. Corneal collagen crosslinking in keratoconus and other eye disease. Int J Ophthalmol. 2015;8(2):407-18.
  10. Doutch JJ, Quantock AJ, Joyce NC, Meek KM. Ultraviolet light transmission through the human corneal stroma is reduced in the periphery. Biophys J. 2012;102(6):1258-64.
  11. Arnalich-Montiel F, Alió del Barrio JL, Alió JL. Corneal surgery in keratoconus: which type, which technique, which outcomes? Int J Ophthalmol. 2015;8(2):407-18.
  12. Turgunbaev NA, Medvedev MA, Bebezov BKh, Polyak AS. Vliyanie krosslinkinga v kombinatsii s posloynoy keratoplastikoy na vnutriglaznoe davlenie pri razlichnykh patologiyakh rogovitsy [Effect of cross-linking in combination with layered keratoplasty on intraocular ocular pressure in various corneal pathologies]. Vestnik KRSU. 2015;15(4):165-6.
  13. Tukhvatshin RR, Turgunbaev NA, Turgunbaev ZhT, Polyak AS. Osobennosti morfologicheskoy kharakteristiki rogovichnoy tkani posle keratoplastiki v kombinatsii s krosslinkingom kollagena rogovitsy v eksperimente [Features of the morphological characteristics of corneal tissue after keratoplasty in combination with corneal collagen crosslinking in the experiment]. Vestnik KRSU. 2014;14(10):192-4.
  14. Medvedev MA, Turgunbaev NA, Ostroverkhov AI. Primenenie krosslinkinga v kombinatsii s glubokoy atipichnoy keratoplastikoy v lechenii daleko zashedshey pellyutsidnoy degeneratsii rogovitsy (otdalyonnye rezul’taty) [The use of crosslinking in combination with deep atypical keratoplasty in the treatment of advanced pellicidal degeneration of the cornea (long-term results)]. Sovremennye tekhnologii v oftal’mologii. 2019;5:296-8.

Authors informations:

Medvedev Mikhail Anatolievich
Doctor of Medical Sciences, Full Professor, Head of the Department of Ophthalmology, Medical Faculty, Kyrgyz-Russian Slavic University
ORCID ID: 0000-0001-5768-2936
E-mail: oculistmm@mail.ru

Bebezov Bakhadyr Khakimovich
Doctor of Medical Sciences, Full Professor, Head of the Department of Hospital Surgery, Medical Faculty, Kyrgyz-Russian Slavic University
ORCID ID: 0000-0002-0724-1849

Turgunbaev Nurlan Aitbaevich
Candidate of Medical Sciences, Senior Lecturer of the Department of Ophthalmology, Medical Faculty, Kyrgyz-Russian Slavic University
ORCID ID: 0000-0002-2627-526X
E-mail: nurlan.turgunbayev@inbox.ru

Ostroverkhov Aleksandr Ivanovich
Senior Lecturer of the Department of Ophthalmology, Medical Faculty, Kyrgyz-Russian Slavic University
ORCID ID: 0000-0002-1989-8573

Information about the source of support in the form of grants, equipment, and drugs

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflict of interest: No conflict

Address for correspondence:

Ostroverkhov Aleksandr Ivanovich
Senior Lecturer of the Department of Ophthalmology, Medical Faculty, Kyrgyz-Russian Slavic University

720000, Kyrgyz Republic, Bishkek, Togolok Moldo str., 1

Tel.: +996 (555) 250330

E-mail: ophtalmologai@gmail.com

Materials on the topic: